Searching...
Wednesday, 29 April 2020

Experimental coronavirus treatment remdesivir delivers 'positive data' in trial, says developer Gilead

The experimental coronavirus treatment remdesivir has generated “positive data” in a trial of the antiviral organized by the National Institute of Allergy and Infectious Diseases (NIAID), according to developer Gilead Sciences.

from FOX News https://ift.tt/2KNq8fa
v

0 comments:

Post a Comment